Spogen Biotech has a total of 356 patents globally, out of which 108 have been granted. Of these 356 patents, more than 88% patents are active. Brazil is where Spogen Biotech has filed the maximum number of patents, followed by United States of America and Australia. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Spogen Biotech.
Spogen Biotech (Elemental Enzymes), founded in 2011, develops patented organic enzymes for commercial agriculture and R&D. Leveraging advanced biotechnology, the company provides stabilized enzymes, proteins, peptides, and specialty chemicals that help address environmental challenges and unlock new market opportunities.
Do read about some of the most popular patents of Spogen Biotech which have been covered by us in this article and also you can find Spogen Biotech patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Spogen Biotech patent portfolio.
How many patents does Spogen Biotech have?
Spogen Biotech has a total of 356 patents globally. These patents belong to 24 unique patent families. Out of 356 patents, 312 patents are active.
How Many Patents did Spogen Biotech File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Spogen Biotech Applications Filed | Spogen Biotech Patents Granted |
| 2025 | 5 | 13 |
| 2024 | 22 | 29 |
| 2023 | 28 | 19 |
| 2022 | 8 | 8 |
| 2021 | 14 | 15 |
| 2020 | 39 | 10 |
| 2019 | 11 | 8 |
| 2018 | 70 | 2 |
| 2017 | 42 | 3 |
| 2016 | 1 | 1 |
How many Spogen Biotech patents are Alive/Dead?
Worldwide Patents
How Many Patents did Spogen Biotech File in Different Countries?
Countries in which Spogen Biotech Filed Patents
| Country | Patents |
| Brazil | 57 |
| United States of America | 56 |
| Australia | 37 |
| Mexico | 23 |
| New Zealand | 22 |
| Europe (EPO) | 17 |
| India | 17 |
| Argentina | 14 |
| Canada | 14 |
| Israel | 13 |
| Chile | 11 |
| China | 10 |
| South Africa | 9 |
| Russian Federation | 7 |
| Indonesia | 4 |
| Ukraine | 3 |
| Colombia | 3 |
| Philippines | 3 |
| Uruguay | 2 |
| Spain | 2 |
| Germany | 2 |
| Viet Nam | 2 |
| Denmark | 2 |
| Africa | 1 |
| Italy | 1 |
| Poland | 1 |
| Austria | 1 |
| Korea (South) | 1 |
| Bolivia | 1 |
| Japan | 1 |
| Paraguay | 1 |
| Costa Rica | 1 |
Where are Research Centres of Spogen Biotech Patents Located?
10 Best Spogen Biotech Patents
CN105263965A is the most popular patent in the Spogen Biotech portfolio. It has received 74 citations so far from companies like Maxygen, Phyllom & Syngenta Participations.
Below is the list of 10 most cited patents of Spogen Biotech:
| Publication Number | Citation Count |
| CN105263965A | 74 |
| WO2016044661A1 | 70 |
| WO2014145964A1 | 62 |
| CN105408468A | 55 |
| WO2014145883A1 | 42 |
| US9573980B2 | 32 |
| CN107208042A | 30 |
| US9845342B2 | 28 |
| US20170347664A1 | 28 |
| CN109640649A | 27 |
What Percentage of Spogen Biotech US Patent Applications were Granted?
Spogen Biotech (Excluding its subsidiaries) has filed 60 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 32 have been granted leading to a grant rate of 91.43%.
Below are the key stats of Spogen Biotech patent prosecution at the USPTO.
Which Law Firms are managing US Patents for Spogen Biotech?
| Law Firm | Total Applications | Success Rate |
| Dentons US Llp | 34 | 100.00% |
| Lewis Rice Llc | 8 | 100.00% |
| Stinson Llp | 8 | 85.71% |
| Bayer Cropscience Lp | 6 | 83.33% |
| Marshall Gerstein & Borun Llp | 3 | 100.00% |
| Shook Hardy & Bacon Llp | 1 | 0.00% |
What are Spogen Biotech key innovation segments?
What Technologies are Covered by Spogen Biotech?
The chart below distributes patents filed by Spogen Biotech in different countries on the basis of the technology protected in patents. It also represents the markets where Spogen Biotech thinks it’s important to protect particular technological inventions.
R&D Focus: How has Spogen Biotech search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Spogen Biotech?
